Rocket


Overview
Financials
News + Filings

 
 

InMed Pharmaceuticals Inc. Add to portfolio


Recent News + Filings   (All items)

Financial Summary   (All financials)
In millions, except per share itemsJun-30-19Jun-30-18
Revenues0.00.0
Cost of goods sold0.00.0
Gross profit0.00.0
General and administrative4.36.1
EBIT-9.5-8.1
Pre-tax income-9.2-8.0
Income taxes0.00.0
            Tax rate0.0%0.0%
Net income-9.2-8.0
 
Diluted EPS($0.05)($0.06)
Shares outstanding (diluted)171.3142.5
 
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy